Trial intelligence / Profile preview

Blood and urinary concentrations of inhaled formoterol in asthmatic subjects and elite athletes with asthma

2009-012039-14Phase 4Completed

Sponsor
Respiratory and Allergy Research Unit
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of formoterol in asthma (3 arms), sponsored by Respiratory and Allergy Research Unit. Primary endpoints: Serum formoterol concentration and Urine formoterol concentration. Started May 2009; status: completed.

02

Drugs

formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on 2009-012039-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012039-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call